Three-Dimensional Dosimetry of the Full and Empty Bladder in High Dose Rate Vaginal Cuff Brachytherapy

2014 ◽  
Vol 24 (5) ◽  
pp. 923-927 ◽  
Author(s):  
Justyna D. Kobzda ◽  
Ewa Cikowska-Wozniak ◽  
Magdalena Michalska ◽  
Roman Makarewicz

ObjectivesThe objectives of the study were to assess the bladder doses during vaginal cuff brachytherapy and to examine the effect of bladder filling on normal tissue dosimetry by means of computed tomography.Materials and MethodsA total number of 45 women were enrolled in a prospective clinical trial. Patients were treated with the application of a single-line source vaginal cylinder. All the patients were asked to consume 400 mL of water 40 minutes before computed tomography scans were taken. For each patient, 2 treatment plans were performed—one with full bladder and the other one when the bladder was emptied. A dose-volume histogram and the equivalent of 2-Gy dose for full and empty bladder were calculated. Doses to the bowels in 2 states of the bladder were estimated.ResultsThirty-five patients received a lower dose to the empty bladder than to the filled organ. The average dose difference was 0.5 Gy. Ten patients received a lower dose to the full bladder than to the empty one. However, in this case, the difference amounted only to 0.2 Gy on average. Dose parameters (the maximal dose received by 0.1 cm3 of tissue and the maximal dose received by 2 cm3 of tissue) were lower in the empty state, but the volumetric parameters (the percent of bladder volume receiving ≥50% of the prescribed dose and the percent of bladder volume receiving ≥80% of the prescribed dose) were higher in the empty state of the bladder. Doses to the bowels seemed to be higher in the empty bladder. However, none of the doses exceeded the limitations.ConclusionsThe results have shown that in most cases, the dose to the empty bladder is lower than when the bladder is full. Simultaneously, the doses to the bowels increase proportionally in the empty state of the bladder comparing to the full organ. Protection of the bowels, which are more radiosensitive, suggests treating the patients in the full state of the bladder. Early and late bowel toxicity should be investigated to establish clear standards of treatment.

Author(s):  
A.J. Stewart ◽  
R.A. Cormack ◽  
L. Xiong ◽  
H. Lee ◽  
J.L. Hansen ◽  
...  

2013 ◽  
Vol 82 (10) ◽  
pp. e509-e514 ◽  
Author(s):  
Federico Collettini ◽  
Anju Singh ◽  
Dirk Schnapauff ◽  
Maciej Janusz Powerski ◽  
Timm Denecke ◽  
...  

2014 ◽  
Vol 3 ◽  
pp. 271-275 ◽  
Author(s):  
Ashraf Hassouna ◽  
Yasir Abdulaziz Bahadur ◽  
Camelia Constantinescu

Author(s):  
Surega Anbumani ◽  
Ramesh S. Bilimagga ◽  
Pichandi Anchineyen ◽  
Punitha Jayaraman ◽  
Siddanna R. Palled

AbstractIntroduction:Cholangiocarcinoma (CCA) or klatskin’s tumour involves malignant tumours at the liver hilum’s biliary confluence. Incidence of CCA results in unresectable tumours that require appropriate therapy to improve quality of life. The liver is considered as the most frequent site of tumour recurrence. Promising results of long-term survival have been established with computed tomography-guided high-dose-rate brachytherapy.Materials and methods:Intraluminal brachytherapy (ILBT) is performed through the percutaneous transhapatic bile duct drain tube (PTBD). The passage of the brachytherapy guide tube through the bile duct is more complex compared with oesophageal/endobronchial application.Results/discussion:It results in a recoiled view of the tube in the abdominal region of the computed tomography (CT) scan. Owing to inherent artefacts induced by metal stents in CT scans, intersected view is possible between the ILBT guide tube and the intra-hepatic drain tube. It would mislead the planner to track wrong passage that could result in fatal error.Conclusion:In this case study, we contoured the ILBT guide tube by cross-verifying its position with a digitally reconstructed radiograph (DRR) before catheter tracking. Thus, it ensures precise simulation of source dwell positions, thereby avoiding high-dose delivery to nearby vital organs such as intestines, liver hilum and blood vessels.


Author(s):  
John M. Anderson ◽  
Tam Nguyen ◽  
Joel Childers ◽  
Alton V. Hallum ◽  
Earl Surwitt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document